Fortress Biotech

A snakebit biotech receives second CRL for reformulated pain med
Endpoints
Mon, 06/14/21 - 10:26 am
Avenue Therapeutics
Fortress Biotech
FDA
Tramadol
post-operative pain
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Alexion Strikes Development Deal With Caelum Biosciences in Rare Systemic Disorder
BioSpace
Thu, 01/31/19 - 11:18 am
Alexion Pharmaceuticals
Fortress Biotech
Caelum Biosciences
CAEL-101
light chain amyloidosis
Special Report: Biotech incubator taps investors through in-house brokerage
Reuters
Fri, 08/3/18 - 09:39 am
biotech
incubators
Avenue Therapeutics
Mustang Bio
Checkpoint Pharmaceuticals
Fortress Biotech
Fortress Bio soars after reporting breakthrough with CAR-T cancer approach
Marketwatch
Thu, 12/29/16 - 10:22 am
Fortress Biotech
CAR-T
MB-101
brain cancer
Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia
Yahoo
Wed, 05/18/16 - 11:18 am
Fortress Biotech
clinical trials
CNDO-109
acute myeloid leukemia